D
EVELOPMENT OF TYPE 2 diabetes occurs when pancreatic ␤-cells are unable to compensate for insulin resistance in peripheral tissues (1) . This is particularly relevant in obese individuals who are commonly insulin resistant. Pancreatic ␤-cells fail to compensate for insulin resistance because of defects in insulin secretion or loss of ␤-cell mass because of cell death (2) . The underlying causes of ␤-cell death are beginning to be uncovered. Inflammatory cytokines such as TNF␣, IL-1␤, and interferon-␥ have been shown to be cytotoxic to ␤-cells (3) and may contribute to ␤-cell death in obesity, which has been described as a state of low-level chronic inflammation (4) . Lipotoxicity has also emerged as a potential contributor to ␤-cell decompensation (5) (6) (7) (8) . Nonesterified free fatty acids (FFA) have been shown to be cytotoxic to ␤-cells in obesity-associated diabetes models as well as in normal ␤-cells from several species (9 -14) .
Although it is believed that lipotoxicity occurs as a result of excess FFA that enter nonoxidative metabolic pathways, the molecular mechanism by which FFA cause ␤-cell death is not completely understood. In the obese diabetic Zucker fatty rat model, excess FFA cause elevated ceramide levels, leading to increased amounts of the inducible isoform of nitric oxide synthase and nitric oxide (NO) generation, which can trigger ␤-cell apoptosis (13) (14) (15) . However, several studies have failed to implicate NO involvement in FFA-induced ␤-cell death (9, 12, 16) . In addition, FFA can be cytotoxic by inducing apoptotic pathways that originate as a result of mitochondrial perturbation and increased oxidative stress (9, 12, 17) .
A recent study by Ozcan et al. (18) has uncovered a link between obesity and endoplasmic reticulum (ER) stress in liver and adipose cells. The ER is involved in folding, processing, and export of newly synthesized secretory and membrane proteins. An increase in the amount of proteins requiring folding or alterations in the ER environment that decreases folding capacity can elicit the unfolded protein response (UPR), a mechanism that counteracts ER stress (19, 20) . When counterregulatory mechanisms such as transient inhibition of protein synthesis, elevated ER chaperone levels, and ER-associated degradation components cannot compensate for the imposed ER stress, cell death pathways are initiated. Pancreatic ␤-cells are particularly sensitive to ER stress because these cells must synthesize and secrete large amounts of insulin to meet metabolic demands (21, 22) .
Given the link between hepatic and fat cell ER stress and obesity, we examined the effects of chronic FFA treatment on UPR signaling in the INS-1 cell culture model of pancreatic ␤-cells. We found that although chronic treatment with either palmitate or oleate was cytotoxic, only palmitate induced significant ER stress.
Materials and Methods Antibodies
Phosphorylated eukaryotic translation initiation factor 2␣ (phosphoeIF2␣) (Cell Signaling, Beverly, MA; no. 9721, 1:500), eIF2␣ (Cell Signaling; no. 9722, 1:500), phosho-PKR-like ER kinase (PERK) (Cell Signaling, no. 3191, 1:500), cAMP response element-binding protein 2/activating transcription factor 4 (ATF4) (Santa Cruz; sc-200, 1:500), growth arrest and DNA damage-inducible protein (GADD153)/C/EBP homologous transcription factor (CHOP) (Santa Cruz; sc-575, 1:500), X box-binding protein 1 (XBP-1) (Santa Cruz; sc-7160, 1:500), anti-KDEL (StressGen Biotechnology, Victoria, Canada; SPA-827, 1:1000), protein disulfide isomerase (PDI) (StressGen; SPA-890, 1:4000), ␥-tubulin (Sigma Chemical Co., St. Louis, MO; T6557, 1:1000), monoclonal antihemagglutinin (anti-HA) (HA.11; Babco Inc., Richmond, CA). A rabbit polyclonal antibody to glucose-regulated protein 78 kDa (Grp78)/Ig heavy chain-binding protein (BiP) was kindly provided by Dr. Ingrid Haas (Max-Planck Institute, Freiberg, Germany).
INS-1 cell culture
Rat INS-1 pancreatic ␤-cells were maintained in RPMI 1640 (11 mm glucose, 1 mm sodium pyruvate, 10 mm HEPES) supplemented with 10% fetal bovine serum (FBS), 2 mm l-glutamine, and 55 m ␤-mercaptoethanol at 37 C/5% CO 2. During FFA stimulation, the above medium was used but in the absence of FBS. All experiments were performed between passages P4 and P20.
FFA preparation, cell treatment, and lyses
FFA solutions were prepared as described previously (23) . Briefly, 100 mm palmitate (Sigma no. P-0500) and 100 mm oleate (Sigma no. O-7501) stocks were prepared in 0.1 m NaOH at 70 C and filtered. Five percent (wt/vol) FFA-free BSA (Sigma no. A-6003) solution was prepared in double-distilled H 2 O and filtered. A 5 mm FFA/5% BSA solution was prepared by complexing an appropriate amount of FFA to 5% BSA in a 60 C water bath. The above solution was then cooled to room temperature and diluted 1:5 in RPMI 1640 without FBS to a final concentration of 1 mm FFA/1% BSA.
INS-1 cells were cultured on 10-cm dishes to 80 -85% confluency and stimulated with 1 mm FFA/1% BSA for 3, 6, 16, and 24 h. One micromolar thapsigargin (1 and 6 h) and 2 g/ml tunicamycin (16 h) were used as positive controls for induction of ER stress. At indicated time points, the cells were washed in PBS and lysed in ice-cold lysis buffer [1% Triton X-100, 20 mm HEPES (pH 7.4), 100 mm KCl, 2 mm EDTA, 1 mm phenylmethylsulfonyl fluoride (PMSF), 10 g/ml leupeptin, 10 g/ml aprotinin, 10 mm NaF, 2 mm Na 3 VO 4 , and 10 nm okadaic acid]. The cells were lysed on ice for 30 -60 min and centrifuged at 13,000 rpm for 10 min at 4 C. The supernatant was then transferred to a new tube, and protein concentration was determined with BCA reagent (Pierce Chemical Co., Rockford, IL; no. 23223).
Cell transfection
INS-1 cells (400,000 cells per well) were seeded onto glass coverslips in 24-well dishes the day before transfection. Cell were transfected with HA-ATF6 plasmid pCGN-ATF6 (obtained from Dr. Ron Pyrews, Columbia University, New York, NY) using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's suggested protocol. Sixteen to 24 h later, the cells were treated as described in the Fig. 6 legend and processed for indirect immunofluorescence microscopy as described below.
Preparation of nuclear extracts
INS-1 cells were treated with FFA or controls as described above. At 6 and 16 h, the cells were washed in PBS and lysed in ice-cold nuclear extraction buffer A [10 mm HEPES (pH 7.5), 10 mm KCl, 1.5 mm MgCl 2 , 0.1 mm PMSF, 10 g/ml leupeptin, 10 g/ml aprotinin, and 1 mm dithiothreitol (DTT)]. The samples were incubated on ice for 30 min, homogenized by passing through 25-gauge needle 10 times, and centrifuged at 13,000 rpm for 30 sec at 4 C to pellet nuclei. The pellet was resuspended in nuclear extraction buffer C [20 mm HEPES (pH 7.9), 10% glycerol, 400 mm NaCl, 40 mm MgCl 2 , 1 mm EDTA, 0.1 mm PMSF, 10 g/ml leupeptin, 10 g/ml aprotinin, and 1 mm DTT] and incubated on ice for 30 min. The samples were then centrifuged at 13,000 rpm for 15 min at 4 C. Nuclear extracts were resolved on SDS-PAGE, transferred to nitrocellulose, and immunoblotted with anti-ATF4 antibody.
Apoptosis assay
The cell death detection kit ELISA PLUS (Roche Diagnostics, Indianapolis, IN) was used to monitor FFA-induced apoptosis. One day before the experiments, INS-1 cells were seeded in 24-well plates (200,000 cells per well). The cells were treated as indicated in the Fig. 1 legend. After the treatment, the cells were lysed and oligonucleosomes in the cytoplasm quantified according to the manufacturer's instructions. Cytoplasmic oligonucleosomes are indicative of apoptosis-associated DNA degradation. Cells grown in the presence of serum had near background levels of cytoplasmic oligonucleosomes, and consequently all other treatment conditions were normalized to this condition at each time point.
Immunofluorescence microscopy
INS-1 cells were seeded on glass coverslips in 24-well dishes. After an overnight incubation, the cells were treated as indicated in the legends to Figs. 5 and 6. After the treatments, the cells were washed twice with PBS and fixed for 20 min in 4% paraformaldehyde/PBS at room temperature. The cells were subsequently washed twice in PBS and incubated in blocking solution for 1 h (2% nonfat milk/2% BSA in PBS). Primary antibodies were added for 1 h at room temperature in blocking solution [mouse anti-KDEL (1:200) or mouse anti-HA (1:1000)]. After three washes (5 min each) in PBS, Oregon green-labeled antimouse secondary (Molecular Probes, Inc., Eugene, OR) was added for 1 h at room temperature. The cells were washed three times (5 min each) and mounted onto glass slides using Fluoromount G mounting medium (Electron Microscopy Sciences, Inc., Hatfield, PA). Confocal images were acquired using a Zeiss laser scanning confocal microscope (Carl Zeiss, Inc., Thornwood, NY).
Electron microscopy
INS-1 cells were fixed with 2% glutaraldehyde in 0.15 m sodium phosphate buffer (pH 7.4) for 30 min at room temperature. The samples were postfixed in 2% OsO 4 , contrasted by en bloc staining with uranyl acetate (24) , dehydrated with alcohol, and embedded in Epon. For immunoelectron microscopy, cells were fixed as above and processed for cryo-ultramicrotomy as described (25) . Ultrathin frozen sections were prepared and incubated for immunolabeling as described (26) . Monoclonal anti-Grp78/BiP antibody (StressGen) was diluted 1:50 and was labeled with goat antimouse IgG gold (gold size, 10 nm).
S labeling and immunoprecipitation
One million INS-1 cells per well were plated in a six-well dish the day before the start of the experiment. The cells were treated with 1 mm FFA/1% BSA (prepared in l-methionine-free RPMI 1640) or 2 g/ml tunicamycin, in the presence of 100 Ci/ml of Tran 35 S-Label (MP Biomedicals, Irvine, CA; no. 51006) for 3, 6, and 9 h at 37 C. At the indicated time points, the cells were washed in PBS and lysed in ice-cold lysis buffer [1% Triton X-100, 20 mm HEPES (pH 7.4), 100 mm KCl, 2 mm EDTA, 1 mm DTT, 1 mm PMSF, 10 g/ml leupeptin, and 10 g/ml aprotinin] for 1 h at 4 C. The lysates were then centrifuged at 13,000 rpm for 10 min at 4 C, and 150 g of the cleared lysate, as determined by BCA assay, was used for immunoprecipitation with rabbit polyclonal Grp78/ BiP antibody at 4 C overnight. The next day, protein A-agarose was added (25 l/immunoprecipitation), and incubation continued for another 2 h at 4 C. The unbound fraction was removed and the pellet was washed four times with 1 ml lysis buffer for 5 min at 4 C. The pellet was resuspended directly in Laemmli sample buffer and protein resolved by SDS-PAGE. The dried gel was exposed overnight in a Molecular Dy-namics phosphor screen, which was scanned using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA) and quantified using ImageQuant software.
[ 3 H]Leucine incorporation into total cellular protein
INS-1 cells (500,000 cells per well) were seeded in 12-well dishes. Forty-eight hours later, the cells were washed in PBS and treated as follows: 1% BSA, 1 mm palmitate/1%BSA, 1 mm oleate/1%BSA, or thapsigargin (1 m), all in serum-free media containing 25 Ci/ml [ 3 H]leucine (PerkinElmer, Boston, MA). After treatment for 3, 6, and 9 h, the cells were placed on ice. The cells were washed twice with ice-cold PBS and lysed in 1% Triton X-100, 20 mm HEPES (pH 7.4), 100 mm KCl, 2 mm EDTA, 1 mm DTT, 1 mm PMSF, 10 g/ml leupeptin, and 10 g/ml aprotinin. Total protein from each condition was precipitated with trichloroacetic acid (9%, final concentration) for 10 min on ice. The precipitates were filtered using Whatman GF/C glass microfiber filters that were preblocked in lysis buffer containing 2% milk. The filters were air dried overnight and bound radioactivity determined by scintillation counting.
Western blot analysis
Equal protein amounts (50 g) were resolved by SDS-PAGE, transferred to nitrocellulose membranes, and immunoblotted with antibodies described above. After incubation with secondary antibody conjugated to horseradish peroxidase, the bands were detected with the enhanced chemiluminescence system (Amersham Biosciences, Piscataway, NJ; RPN2106). Immunoblots were scanned and quantified using Scion Image software.
Measurements of cytosolic free Ca 2ϩ
INS-1 cells were seeded onto glass coverslips 1 d before the experiment. The cells were treated as indicated in the Fig. 9 legend for 6 h before the calcium measurements were initiated. The cells were loaded in RPMI medium with 3 g/ml fura-2-AM for 30 min at 37 C under 5% CO 2 . The coverslip was then placed in a thermostated Leiden chamber holder on the stage of a microscope (IM-35; Carl Zeiss) equipped with a ϫ40, 0.75 numerical aperture UV-I objective. A filter wheel (Sutter Instruments, Novato, CA) was used to alternately position the two excitation filters (340 Ϯ 10 and 380 Ϯ 10 nm; Chroma Technologies Corp., Brattleboro, VT) in front of a mercury lamp. The excitation light was directed to the cells via a 400-nm dichroic mirror. The data were recorded every 5-20 sec by irradiating the cells for 600 msec (340 nm) and 200 msec (380 nm) at each of the excitation wavelengths followed by acquisition of a bright-field image using Nomarski optics. Image acquisition was controlled by Metafluor software V 6.3 (Universal Imaging Corp., West Chester, PA). The emitted light was directed onto a dual bandpass (515 and 660 nm) emission filter placed in front of an Orca ER camera (Hamamatsu Photonics, Hamamatsu City, Japan) set to bin pixels by 8. The bright-field image was continuously monitored by placing a second 620-nm dichroic mirror in the light path to direct the nearly infrared light to a CCD-72 video camera (Dage MTI, Michigan City, IN). After mounting, the cells were washed once with Ca 2ϩ -containing solution (140 nm NaCl, 5 mm KCl, 1 mm MgCl 2 , 10 mm glucose, 20 mm HEPES, 100 m EGTA, and 1.1 mm CaCl 2 , pH 7.4). After basal measurements were made, the cells were placed in Ca 2ϩ -free solution (140 nm NaCl, 5 mm KCl, 1 mm MgCl 2 ,10 mm glucose, 20 mm HEPES, and 100 m EGTA, pH 7.4), and the ER Ca 2ϩ stores were assessed by addition of 1 m TG. The ratio of fluorescence intensity (F), F 340nm /F 380nm , for each cell was then normalized to the maximum determined in each individual measurement by treatment with 10 m ionomycin in Ca 2ϩ -containing solution.
Data analysis
Results are presented as mean Ϯ se. Statistical significance between two conditions was analyzed by the Student's paired t test and between several groups using one-way ANOVA, where P Ͻ 0.05 was considered statistically significant.
Results

Chronic FFA treatment induces ␤-cell apoptosis
FFA have been shown to induce apoptosis in pancreatic ␤-cell lines as well as in primary cultured ␤-cells (9 -12, 14, 16, 27) . In cultured cells and isolated islets, FFA treatments have been performed in both the presence and absence of serum. Generally, in the presence of serum, a longer incubation time is needed to observe cytotoxic effects in normal ␤-cells. We chose to perform the FFA treatments under serum-free conditions because this experimental paradigm has been used previously and has been suggested to potentially mimic the situation in type 2 diabetes (12).
We initially examined the effect of FFA treatment on apoptotic cell death in INS-1 pancreatic ␤-cells (28) . Using a commercial kit that measures cytoplasmic histone-associated DNA fragments, a hallmark of apoptotic cells (29) , little if any apoptosis was observed in control cells grown in the presence of serum. Treatment of the cells in serum-free conditions INS-1 cells were treated with 0.5% BSA, 1% BSA, 0.5 mM palmitate/0.5% BSA, 1 mM palmitate/1% BSA, 0.5 mM oleate/0.5% BSA, or 1 mM oleate/1% BSA in media without serum for the times indicated on the x-axis. The cells were washed and subjected to lysis as described in Materials and Methods. Apoptosis was assessed using the cell death apoptosis kit (Roche) that measures the amount of cytoplasmic DNA-associated histone complexes. The levels of these complexes were slightly above background in cells grown in the presence of serum (ϩFBS), and consequently the values in all other conditions were normalized to cells grown in serum for each time point. Shown are the mean Ϯ SE of three to five independent experiments with each condition performed in duplicate. *, P Ͻ 0.05; **, P Ͻ 0.01 vs. control (BSA).
resulted in a small increase in the amount of apoptotic cells after 24 h ( Fig. 1 ; BSA). Significant apoptosis above BSAtreated controls was apparent after 24 h of treatment with 0.5 mm oleate and after 16 -24 h of treatment with 1.0 mm oleate or palmitate (P Ͻ 0.05; Fig. 1 ). There was no difference in the extent of apoptosis induction by 0.5 mm compared with 1.0 mm palmitate, whereas 0.5 mm oleate tended to induce less ␤-cell apoptosis than 1.0 mm oleate. Consistent with previous findings, palmitate was more toxic to ␤-cells than oleate (10, 16) . We also assayed the medium of FFA-treated INS-1 cells for histone-associated DNA fragments. This measures cell necrosis, which is characterized by disruption of the plasma membrane and leakage of cell contents. We noticed that palmitate treatment at both 0.5 and 1.0 mm caused increased levels of histone-associated DNA fragments, whereas oleate had no significant effect (P Ͻ 0.05) (supplemental Fig. 1 , published as supplemental data on The Endocrine Society's Journals Online web site at http://endo.endojournals.org). Our results are consistent with reported findings showing that chronic oleate treatment causes little or no necrosis (10, 27, 30) , whereas palmitate at 0.5 mm induces significant pancreatic ␤-cell necrosis (10, 30).
Palmitate but not oleate induces UPR signaling pathways
To determine whether FFA-induced ␤-cell death occurs as a result of ER stress, we examined whether FFA treatment can activate ER stress pathway signaling. ER stress activates three signal transduction cascades that emanate from the ER: the PERK, inositol-requiring enzyme 1 (IRE1), and ATF6 pathways (reviewed in Refs. 19 and 20) . The PERK pathway is activated by autophosphorylation of the PERK kinase after ER stress (31) . As shown in Fig. 2 , top, treatment of ␤-cells with thapsigargin, a sarcoplasmic or endoplasmic reticulum calcium ATPase Ca 2ϩ -ATPase blocker that depletes ER Ca 2ϩ stores and is known to cause ER stress, caused the appearance of phosphorylated PERK. Interestingly, chronic treatment with 1.0 mm palmitate, but not oleate, also resulted in the appearance of phosphorylated PERK. Once activated, the PERK kinase phosphorylates the protein eIF2␣ (31) . Phosphorylated eIF2␣ attenuates general protein translation but, in addition, selectively activates the translation of the ATF4 transcription factor mRNA (32). Palmitate but not oleate treatment increased nuclear ATF4 protein levels (Fig. 2, bot- tom), although both FFA increased the levels of phosphorylated eIF2␣ by 3 h of treatment (Fig. 3, A-C) . However, only the palmitate-induced increase was significant based on band density analysis (P Ͻ 0.05; Fig. 3C ). We also noticed that cells grown in the absence of serum for 16 -24 h had elevated levels of phosphorylated eIF2␣ compared with control cells grown in serum.
The second ER stress pathway monitored was the IRE1 signaling pathway. IRE1, when activated, results in increased levels of the transcription factor XBP-1 (33, 34) . Palmitate-treated cells had elevated XBP-1 protein levels by 6 h of treatment, an effect not observed with oleate treatment (Fig. 3, A and B) . We also tested the effect of 0.5 mm palmitate on UPR pathway activation and observed similar results to that obtained with 1.0 mm palmitate (supplemental Fig. 2) .
Upon activation, both of these UPR signaling pathways lead to elevated transcription and subsequent translation of several classes of genes, including the major ER chaperone proteins such as Grp78/BiP (19, 20) . Interestingly, however, the steady-state protein levels of none of the major ER chaperones tested (Grp78/BiP, Grp94, and PDI) was altered by either chronic oleate or palmitate treatment (Fig. 3) . As a positive control, treatment with tunicamycin, a commonly used pharmacological ER stress inducer, caused increased steady-state protein levels of both Grp78 and Grp94 (Fig. 3) .
In the face of persistent ER stress, the PERK and IRE1 signaling pathways induce transcription and translation of proapoptotic factors such as the protein CHOP/GADD153 (35) . By 6 h of treatment with 1 mm palmitate, CHOP protein levels were significantly elevated, an effect not observed with oleate treatment (P Ͻ 0.05; Fig. 3D ). Palmitate at 0.5 mm induced a similar increase in CHOP protein levels (supplemental Fig. 2B ). Apart from inducing slightly the phosphorylation of eIF2␣, oleate did not appear to elicit UPR signaling pathways in INS-1 cells even at high (1 mm) concentrations.
Chaperone protein levels are not increased by FFA treatment
Despite clearly activating the UPR signaling pathways, palmitate treatment did not elevate steady-state ER chaperone protein levels (Fig. 3 , E and F, and supplemental Fig. 2 ). This was surprising given the known effects of UPR pathway signaling leading to induction of ER chaperones (19, 20) and the fact that a recent study has reported that FFA augment Grp78 mRNA by about 2-fold (16 (Fig. 4) . Thus, palmitate-activated UPR signaling, as opposed to pharmacological induction of UPR signaling, does not lead to induction of chaperone protein levels.
Palmitate alters the ER morphology in INS-1 ␤-cells
We also examined the localization of the ER chaperone proteins in control and FFA-treated INS-1 cells by immunofluorescence microscopy using an antibody recognizing the KDEL sequence. Control cells had a typical reticular ER FIG. 2. Palmitate but not oleate induces PERK kinase phosphorylation and ATF4 activation. INS-1 cells were treated with 1% BSA (control), 1 mM oleate/1% BSA, 1 mM palmitate/1% BSA, or 1 M thapsigargin (Thaps.) for the indicated times. After the treatments, either whole-cell lysates or nuclear extracts were prepared (see Materials and Methods). Whole-cell lysate fractions were immunoblotted using an anti-phospho-PERK antiserum (top), and the nuclear fractions were immunoblotted using an ATF4-specific antiserum (bottom).
staining pattern throughout the cell (Fig. 5B) . However, exposure of the cells for 6 h to palmitate, but not oleate, altered the fluorescence distribution. The KDEL signal in palmitatetreated cells appeared in large bright punctate/aggregate structures, both close to the nucleus and near the cell periphery (Fig. 5E ). There were also areas in the cell (in addition to the nucleus) that were completely devoid of labeling. This punctate/aggregate distribution was also observed in cells treated with thapsigargin, although the labeling appeared throughout the cell (Fig. 5F ). Comparable results were obtained using an antibody specific for Grp78. A similar KDEL and Grp78 localization was observed after treatment of INS-1 cells with 0.5 mm palmitate/0.5% BSA (results not shown).
The morphology of the palmitate-treated cells at the light microscopy level was also abnormal as the cells appeared condensed and angular (Fig. 6 bottom right) . These morphological changes were not elicited by oleate treatment (Fig. 6,  middle right) . Because the localization of ER chaperones and . After the treatment, the cells were lysed and immunoblotted using anti-phospho-eIF2␣, XBP-1, Grp78/94, PDI, GADD153/CHOP, and tubulin antibodies. Western blots were scanned and quantified using Scion Image software. All values were normalized to a loading control (tubulin). C-F, Fold induction was determined as a ratio of FFA-treated over BSA-treated values at the same time point. An average of at least three independent experiments is shown (ϮSE). *, P Ͻ 0.05; **, P Ͻ 0.01 vs. control.
Grp78 was markedly altered by palmitate (Fig. 5) , we examined the effect of palmitate on a transmembrane ER protein. We transiently transfected INS-1 cells with the ER targeted transmembrane protein ATF6 (tagged with an HA epitope) (36) . The protein had a typical reticular staining pattern in control and oleate-treated cells (Fig. 6, top and  middle) . However, in palmitate-treated cells, the distribution of the fusion construct was markedly altered. The HA-ATF6 protein was distributed around the nucleus and periphery of the cell, and there were large areas within the cell completely devoid of the protein (Fig. 6, bottom left) .
Our results at the light microscopy level suggested that palmitate was altering ER morphology. Indeed, by electron microscopy, we observed a markedly altered cell morphology in palmitate-treated INS-1 cells by as little as 30 min of treatment (Fig. 7, A compared with B) . In palmitate-treated cells, we observed electron-lucent clefts extending throughout the cytoplasm. In many places, no limiting membrane was visible in these clefts, but in some cases they were clearly in continuity with the lumen of the ER, suggesting that they arose from an altered ER (Fig. 7C) . The ER chaperone Grp78 is localized along the inner area of the electron-lucent structures, supporting the fact that these structures are continuous with the ER (Fig. 7D) . Interestingly, we observed very limited alterations of the nuclear envelope in these cells despite the continuity of the nuclear envelope with the ER. These results are similar to a very recent study showing that the ER morphology in INS-1 cells treated with palmitate for 24 h was severely dilated, apparently because of the accumulation of tripalmitin in the ER (37) . In addition, we observed altered mitochondrial and Golgi morphology in palmitate-treated cells (Fig. 7, E and F) . Similar morphological changes were observed with 0.5 mm palmitate (supplemental Fig. 3 ).
Palmitate does not enhance translation or significantly alter ER Ca 2ϩ homeostasis
As shown above, chronic palmitate treatment activates UPR signaling pathways. UPR signaling is initiated by increased demand for protein-folding capacity, which titrates ER chaperones away from the luminal domains of ER stresssensing proteins, causing their activation (38, 39) . This can occur if misfolded proteins accumulate during pathophysiological conditions or by enhanced translation that may oc- cur physiologically, such as in glucose-stimulated ␤-cells (22) . Thus, it is possible that palmitate enhances translation acutely, leading to an increase in ER client protein load and consequently activation of UPR pathways. As shown in Fig.  8 , however, treatment with oleate or palmitate for 3-9 h actually causes a small reduction in general translation rate as measured by incorporation of radiolabeled leucine into total cellular protein, although this was not significant. This is consistent with the increased levels of phosphorylated eIF2␣ after FFA treatment (Fig. 3) .
Because translation rates are not enhanced by FFA, even at early time points after treatment, it is possible that palmitate gradually causes the accumulation of misfolded proteins in the ER. Accumulation of misfolded proteins can occur when the ER luminal environment is perturbed. One such perturbation could be depletion of ER Ca 2ϩ levels. We therefore examined the effect of FFA on cytoplasmic Ca 2ϩ levels in pancreatic INS-1 cells. Cytoplasmic calcium levels can be monitored by the membrane-permeant calcium indicator fura-2-AM (40) . Cells can subsequently be exposed to thapsigargin, which dissipates ER calcium stores resulting in increased cytosolic calcium that indirectly reflects ER Ca 2ϩ levels (41) . Palmitate or oleate-treated cells had a similar cytoplasmic calcium increase after thapsigargin addition as BSA-treated controls, indicating that FFA treatment does not significantly alter ER Ca 2ϩ concentrations (Fig. 9) . Therefore, alteration in ER Ca 2ϩ homeostasis is unlikely to be the underlying mechanism of how palmitate induces ER stress.
Discussion
Obesity is a major risk factor for the development of type 2 diabetes. Chronically elevated FFA may contribute to the progression of this disease by promoting pancreatic ␤-cell death (5) (6) (7) (8) . Consistent with previous observations (9 -12, 14, 16, 27) , chronic (16 -24 h) treatment of pancreatic ␤-cells with palmitate or oleate induces considerable ␤-cell apoptosis (Fig. 1) . In this study, the FFA treatment was performed under serum-free conditions, where both palmitate and oleate have been shown to markedly enhance apoptosis (12) , possibly as a result of the lack of leptin, a hormone with lipotoxicity-protective properties (42) . Thus, serum-free conditions may mimic in a cellular context both the oxidative stress situation that occurs in type 2 diabetes (12) as well as leptin resistance that may contribute to lipotoxicity in dietinduced obesity (8) . In addition, our studies were performed in media containing 11.1 mm glucose, which is higher than basal levels (3-5 mm) and may contribute to the cytotoxic effects we observed.
The recent finding that obesity is associated with cellular ER stress in several tissues (18) suggests that ER stress could play a role in FFA-induced ␤-cell death. Cellular ER stress activates three distinct signaling pathways that are initiated by stress-sensing proteins located in the ER membrane. The PERK, IRE1, and ATF6 signaling pathways have been extensively characterized (19, 20) . Collectively, these UPR signaling pathways initiate cell-protective mechanisms that attempt to restore ER protein-folding capacity by transiently inhibiting translation (PERK pathway) and inducing a variety of gene products that either enhance protein folding capacity (ER chaperone proteins) or degrade terminally misfolded or aggregated proteins (ER-associated degradation system). In the face of persistent ER stress, however, apoptotic pathways are initiated. The CHOP/GADD153 transcription factor (35) , caspases (43) , and c-Jun N-terminal kinase (44, 45) have been implicated in this aspect of the UPR, although the downstream pathways are only beginning to be characterized (46, 47) .
Here we report that although both of the FFA induced ␤-cell apoptosis, only palmitate activated the PERK and IRE1 pathways of the UPR (measured by phospho-PERK, ATF4, and XBP-1 protein levels). Furthermore, palmitate, but not oleate, up-regulated the levels of the CHOP transcription factor, which in part mediates ER stress-induced cell death (35) . What is particularly striking is the fact that although palmitate clearly activates PERK and IRE1 signaling, the main ER chaperone target genes of these signaling pathways are not induced by palmitate (19) . Thus, it appears that the beneficial aspects of UPR induction are bypassed and the destructive aspects (CHOP induction) are induced by this fatty acid.
The fact that palmitate does not up-regulate Grp78 expression is somewhat surprising because the IRE1/XBP-1 pathway signaling has been described to be involved in inducing transcription of ER chaperone genes such as Grp78 (34) . However, the ATF6 signaling pathway of the UPR has also been implicated in inducing chaperone expression (19, 48) . Furthermore, ATF6 can induce Grp78 transcription in the absence of XBP-1 and appears to be the predominant pathway for Grp78 induction (49). Thus, it is possible that palmitate does not activate the ATF6 pathway in INS-1 cells. Whether palmitate can induce the ATF6 pathway remains to be tested. A recent report has shown that FFA can activate a luciferase-based ATF6 promoter construct transfected into INS-1 cells (16) . However, this is not evidence that the ATF6 pathway is activated because activation of ATF6 involves its translocation from the ER to the Golgi, where it undergoes proteolysis releasing the cytosolic transcriptional activation domain (50) .
Our results differ somewhat from Kharroubi et al. (16) , who recently reported, based on real-time RT-PCR analysis, that both oleate and palmitate increased the mRNA levels of ATF4 (ϳ50%) and BiP (ϳ2-fold) after 24 h of treatment. However, the protein levels of these gene products were not measured in that study. Furthermore, several microarray studies have failed to detect increases in mRNA abundance of common ER chaperones in response to FFA treatment (51) (52) (53) . Thus, it is unlikely that FFA elevate Grp78 protein levels to a significant degree. Our results show that palmitate is unable to induce Grp78 expression, and as a consequence, the ␤-cell is deprived of one of the main survival mechanisms during ER stress.
How does palmitate induce ER stress? Palmitate does not enhance protein synthesis; thus, it is not increasing ER client protein load. Our results suggest that palmitate might alter the ER environment and as a consequence cause the production of misfolded proteins. Although we have no direct evidence for this, palmitate does significantly alter the distribution of the major ER chaperone Grp78 from a normally reticular ER localization pattern to a largely punctate/aggregated distribution, similar to the effect caused by thapsigargin. Furthermore, a similar abnormal distribution of Grp78 has been observed in cells treated with proteasome inhibitors, which prevent ERassociated degradation (54) . Finally, a recent study in a mouse model of diabetes has shown that newly synthesized proinsulin is bound to Grp78 and accumulates in the ER of mouse ␤-cells exposed to high-fat feeding (55) .
The drastic palmitate-induced ER morphological perturbation that we observed was reported during the course of our studies (37) . This report observed that after 24 h of palmitate exposure, INS-1 cells accumulated insoluble tripalmitin triglyceride within the ER that likely causes the gross ER morphology observed (37) . Here we also show that ER morphology is altered after only a short palmitate exposure of 30 min, although it takes significantly longer (ϳ6 h) before ER stress pathways are activated.
It is possible that the tripalmitin accumulation in the ER alters the protein-folding environment, increasing the amount of misfolded protein, which in turn activates the UPR. There are several possible ER perturbations that would decrease protein-folding capacity, such as depletion of ER Ca 2ϩ levels, inhibition of normal glycosylation, or alterations in ER redox state. It is unlikely that alterations in ER Ca 2ϩ have a major role because no significant effect was observed in ER releasable Ca 2ϩ stores in FFA-treated cells. The means by which palmitate affects ER homeostasis that ultimately leads to ER stress induction requires additional study.
Although not as potent as palmitate, oleate is also cytotoxic to ␤-cells. In this study, we show that ER stress induction does not appear to be a major contributor to oleate-induced ␤-cell death. As mentioned in the introductory section, both oleateand palmitate-induced pancreatic ␤-cell death can also be initiated by additional mechanisms (9, 12, 14, 17) . The fact that palmitate also significantly induces ER stress in ␤-cells may explain the higher cytotoxic potential of this fatty acid (10, 16) .
In summary, we have shown that palmitate but not oleate induces significant ER stress contributing to INS-1 pancreatic ␤-cell apoptosis. Future studies are required to determine the nature of the ER perturbations elicited by palmitate to ultimately cause ER stress as well as the molecular basis behind the lack of chaperone (Grp78) induction after palmitateinduced ER stress. Finally, oleate in combination with palmitate has been shown to prevent to some degree the deleterious effects of palmitate (56) . It will be interesting to determine whether oleate can protect against palmitate-induced ER stress. 
